STEMI process metrics | Requirement |
STEMI patients receiving ASA on arrival (no contraindication to ASA) |
>95% |
STEMI patients receiving ASA at discharge (no contraindication to ASA) |
>95% |
Heart Attack Patients Given ACE Inhibitor or ARB for Left Ventricular Systolic Dysfunction (LVSD) (no contraindication to ACE and ARBs) |
>90% |
Statin at discharge in patients with dyslipidemia (no contraindications to statin use)) |
>95% |
STEMI Patients Given Smoking Cessation Advice/Counseling |
>95% |
STEMI Patients Given Beta Blocker at Discharge (no contraindication to beta-blocker use) |
>95% |
STEMI Patients Given PCI Within 90 Minutes Of Arrival |
>80% |
Readmission within 30 days for an unanticipated problem related to the initial STEMI |
<20% |
STEMI outcome metrics | |
In-hospital risk-adjusted mortality for STEMI patients receiving PCI |
<7.5% |
Unadjusted in-hospital mortality for STEMI patients |
<10% |
Transfusion of whole blood or RBCs post PCI (excluding CABG patients)* |
<7% |
Major bleeding (excluding CABG patients)** |
<12% |
PCI process metrics | Requirement |
ASA at discharge for all PCI patients (no contraindication to ASA) |
>99% |
Additional antiplatelet drug for stent patients at discharge (no contraindications noted) |
>99% |
Lipid lowering agent at discharge in patients with dyslipidemia (no contraindications to statin use) |
>90% |
Measurement of case appropriateness in a minimum of 75% of all cases performed. (The case appropriateness metrics will be reported in future versions of the NCDR) |
|
PCI outcome metrics | |
Vascular access injury requiring surgery or major bleeding** |
<2.0% |
Emergency CABG |
<1.0% |
Transfusion of whole blood or RBCs post PCI* |
<5.0% |
Post-procedure stroke |
<1.0% |
In-hospital risk-adjusted mortality (excluding STEMI) |
<1.0% |
In-hospital risk-adjusted mortality for all patients |
<2.0% |
Diagnostic Cath Process Metrics | |
Incidence of non-obstructive disease in elective patients, diagnostic only labs |
<50% |
Incidence of non-obstructive disease in elective patients at all other labs † |
<40% |
Diagnostic Cath Outcome Metrics | |
Vascular access injury requiring surgery or major bleeding** |
<1.0% |